dcgo-20260616
___________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): June 16, 2026
___________________________________
DOCGO INC.
(Exact name of registrant as specified in its charter)
___________________________________
Delaware | 001-39618 | 85-2515483 | ||||||||||||
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
685 Third Avenue, 9th Floor, New York, New York | 10017 | |||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
(844) 443-6246 | ||||||||||||||
(Registrant's telephone number, including area code) | ||||||||||||||
N/A | ||||||||||||||
(Former name or former address, if changed since last report) | ||||||||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||||||||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Common stock, par value $0.0001 per share | DCGO | The Nasdaq Stock Market LLC | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 16, 2026, DocGo Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) at 12:00 p.m. Eastern Time. As of the close of business on April 20, 2026, the record date for the Annual Meeting, there were 98,778,413 shares of common stock entitled to vote at the Annual Meeting. The results of the matters voted upon at the Annual Meeting were as follows:
1. Election of the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified:
Director Nominee | Votes For | Votes Withheld | Broker Non-Votes | ||||||||
Vina Leite | 31,241,093 | 18,924,442 | 21,849,313 | ||||||||
James M. Travers | 25,062,607 | 25,102,928 | 21,849,313 | ||||||||
Pursuant to the foregoing votes, the two nominees listed above were elected to serve on the Company’s Board of Directors. There were no additional director nominations brought before the Annual Meeting.
2. To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers:
Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||
39,768,972 | 10,213,238 | 183,325 | 21,849,313 | ||||||||
Pursuant to the foregoing vote, the stockholders approved on a non-binding, advisory basis the compensation of the Company’s named executive officers.
3. To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 to be determined in the sole discretion of the Company’s Board of Directors.
Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||
66,141,612 | 5,673,628 | 199,608 | — | ||||||||
Pursuant to the foregoing vote, the stockholders approved the proposed reverse stock split.
4. To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Charter”) regarding the waiver of corporate opportunities (the “Corporate Opportunity Amendment”):
Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||
40,810,518 | 8,726,933 | 628,084 | 21,849,313 | ||||||||
Pursuant to the foregoing vote, stockholders representing the requisite number of shares did not approve the Corporate Opportunity Amendment necessary to amend the Charter.
5. To approve an amendment to the Charter to limit the liability of certain officers as permitted by Delaware law (the “Officer Exculpation Amendment”):
Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||
43,427,921 | 5,990,544 | 747,070 | 21,849,313 | ||||||||
Pursuant to the foregoing vote, stockholders representing the requisite number of shares did not approve the Officer Exculpation Amendment necessary to amend the Charter.
6. Ratification of the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026:
Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||
67,639,242 | 3,874,903 | 500,703 | — | ||||||||
Pursuant to the foregoing vote, the stockholders ratified the appointment of Urish Popeck & Co., LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DOCGO INC. | |||||
By: | /s/ Ely D. Tendler | ||||
Name: | Ely D. Tendler | ||||
Title: | General Counsel and Secretary | ||||
Date: June 18, 2026
2